Healthcare prior authorization is becoming an operations design problem

Prior authorization used to sound like a payer policy issue.

In 2026, it looks much more like an operations issue.

The reason is simple:

• decision windows are tightening
• documentation expectations are not getting simpler
• providers still lose hours every week to manual follow-up
• denials and appeals still create expensive rework after care is already underway

That combination is pushing healthcare organizations toward a different conclusion:

the real problem is not only the rule. It is the workflow.

Why this is becoming more urgent now

CMS proposed another round of prior authorization reform on April 10, 2026.

The proposed rule would expand electronic prior authorization for drugs and tighten decision windows, including 24 hours for certain drug requests and 72 hours for expedited requests in affected programs and plans.

That matters because the operational bar is getting higher.

If payers, providers, and support teams are still moving requests through portals, inboxes, attachments, and spreadsheets by hand, faster deadlines do not remove the burden. They compress it.

The American Medical Association's 2025 physician survey shows how much drag still exists:

• practices complete 39 prior authorization requests per physician per week
• physicians and staff spend 13 hours per week on those requests
• 40% of physicians report having staff dedicated exclusively to prior auth

The American Hospital Association's March 2026 cost data points in the same direction. Hospitals spent $43 billion in 2025 trying to collect payments already owed, with prior authorization, denials, documentation churn, and appeals all contributing to the burden.

This is not a niche annoyance. It is a throughput problem sitting inside clinical operations and revenue cycle work.

What this trend means for healthcare operators

Many healthcare leaders still talk about prior authorization as if the main answer is lobbying or policy advocacy.

That matters. It is just not enough.

Even if the rules improve, organizations still need a better internal operating model for:

• intake
• status tracking
• documentation gathering
• payer-specific routing
• denial follow-up
• appeal packet preparation

Without that, the organization ends up paying for reform twice:

once in compliance work, and again in the manual coordination required to keep up.

Where the workflow usually breaks

The slowest parts are rarely the purely clinical ones.

They are usually the handoffs:

• a request comes in through one system and supporting records live in another
• a missing field is discovered late
• staff need to re-enter data into a portal
• the denial reason is buried in a fax, PDF, or portal message
• the appeal packet gets rebuilt from scratch instead of assembled from known artifacts

That is why prior authorization increasingly behaves like a back-office workflow problem.

The clinical judgment is important. But the delay often comes from coordination work around the judgment.

What stronger automation looks like

Good prior authorization automation should not mean "remove humans."

It should mean:

• prefill repetitive fields from the EHR or billing system
• gather required documentation before submission
• route urgent vs. standard requests correctly
• track payer response clocks automatically
• flag denials with explicit reason codes or missing evidence
• assemble appeal packages with source documents already attached
• escalate only the cases that actually require human review

That is a much more useful target than a generic "healthcare AI" rollout.

The best near-term wins are narrow, boring, and measurable.

Examples:

• specialty medication prior auth
• imaging approval workflows
• infusion authorization follow-up
• referral and benefits verification handoffs
• denial and appeal assembly for recurring request types

Why buyers should care now

Healthcare organizations are already dealing with thin margins, staffing pressure, and increasing patient complexity.

When prior authorization remains manual, it creates costs in four places at once:

• clinician and staff time
• delayed care
• slower cash collection
• preventable denial and appeal volume

That is why the buying question is changing.

It is no longer only:

Can this system help with prior auth?

It is:

Can this workflow move faster, with fewer touches, inside the stack we already use?

That is the more useful question.

And in 2026, it is becoming the more urgent one.

Sources

• CMS, "2026 CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule"
• American Medical Association, "Fixing prior auth: Nearly 40 prior authorizations a week is way too many"
• American Hospital Association, "Costs of Caring"

If prior authorization is still running on inboxes, portals, and spreadsheet chasing, our healthcare page is the best place to see how we scope these workflows. For a directional business case first, run the calculator.